logo
The key to getting vitamin D in winter without using supplements

The key to getting vitamin D in winter without using supplements

Independent14-05-2025
A new study has found the key to maintaining vitamin D levels in winter.
Regular, moderate-intensity exercise helps maintain crucial vitamin D levels during the darker months – even without weight loss or supplements.
Researchers discovered that overweight and obese adults who participated in a 10-week indoor exercise programme during the darker months experienced significantly less decline in vitamin D compared to a non-exercising control group.
This effect was observed even though participants' weight was deliberately kept stable, demonstrating that the benefit stems from the exercise itself, rather than weight loss or supplementation.
The key to getting vitamin D in winter without using supplements
Exercise completely preserved the body's active form of vitamin D, which plays a key role in supporting bone health, the immune system, and various organs.
Previous studies suggest that vitamin D supplements alone do not help maintain this active form.
The small-scale study was led by academics from the University of Bath, University of Birmingham and University of Cambridge.
Lead author Dr Oly Perkin, from the University of Bath, said: 'This is the first study to show that exercise alone can protect against the winter dip in vitamin D.
'It's a powerful reminder that we still have lots to learn about how exercise benefits our health.'
People who exercised saw a smaller drop in their overall vitamin D levels over winter of around 15%, compared with a 25% drop in those who did not exercise.
Those who exercised kept healthy levels of the active form of vitamin D, which helps support the immune system and bone health.
In the non-exercising group, levels of this active form fell by 15%.
Weight was kept stable throughout the study, proving the effect was due to exercise, not weight loss.
To ensure sunlight did not skew results, the study ran between October and April – when natural vitamin D production from sunlight is minimal in this part of the UK – and participants were asked to avoid supplements.
A previous study from the team showed that a single workout can briefly boost vitamin D levels, but this is the first to show that regular cardio exercise can maintain basal circulating vitamin D levels and offer lasting protection during the winter months.
Principal investigator Professor Dylan Thompson, from the University of Bath, said: 'Collectively, the findings from the VitaDEx project show that exercise increases the concentrations of vitamin D metabolites each time you are active and, on top of this, doing regular activity helps to maintain your basal resting levels of vitamin D during winter.
'This means exercise gives you a double benefit to your vitamin D, first in and around each exercise bout, and second through changing your baseline levels.'
The study offers compelling evidence that exercise could be an effective winter vitamin D strategy, especially for those who are overweight or obese for whom vitamin D supplements are less effective.
Liam Kilawee, who took part in the study, said: 'I was impressed on how thorough the process was and how the team engaged with me during research period.
'The results were pleasing as I could see that my actions had a positive reaction.'
– The study, Exercise without Weight Loss Prevents Seasonal Decline in Vitamin D Metabolites: The VitaDEx Randomised Controlled Trial, is published in the journal Advanced Science.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘Hi-tech' hearing aids are also available on the NHS
‘Hi-tech' hearing aids are also available on the NHS

The Guardian

time6 minutes ago

  • The Guardian

‘Hi-tech' hearing aids are also available on the NHS

The closing paragraphs of Lucy Knight's article ('I'm carrying survivor's guilt': Raymond Antrobus on growing up deaf, 9 August) may have left readers with a misleading impression of the services and quality of hearing aids provided by the NHS. 'Hi-tech' hearing aids that connect to a smartphone are standard issue with the NHS. True, the very latest models of hearing aids may only be available privately (though, like smartphones, I suspect that the upgrades are often minimal). Like the private sector, the NHS provision of hearing aids is also regularly upgraded. The replacement hearing aids I got this January provide excellent sound, and are a conduit for all the radio and podcast listening I need. Not a bad VoakesBradford Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.

NHS to hand out more fat jabs after private clinics raise prices
NHS to hand out more fat jabs after private clinics raise prices

Telegraph

time6 minutes ago

  • Telegraph

NHS to hand out more fat jabs after private clinics raise prices

The NHS will prescribe the weight-loss jab Mounjaro to more people in response to a dramatic price increase for private patients, The Telegraph can reveal. GPs are being braced for a surge in demand for the 'King Kong' of weight-loss jabs after Eli Lilly, the US pharmaceutical firm, said it would be more than doubling its prices from Sept 1. Health officials have written to family doctors about an expected increase in demand from patients who had been accessing the drug privately, but will now turn to the NHS. The Government is also looking to intervene in the dramatic price rise, it is understood, amid fears that hundreds of thousands of patients currently benefiting from losing weight on the jabs could be forced to stop taking them. Eli Lilly said it was increasing the cost of Mounjaro – also known as tirzepatide – in the UK to bring it in line with 'other developed nations'. In July, Donald Trump demanded that drug manufacturers lower their prices for American patients and stop other countries 'freeloading' off US firms. The US president previously complained that a friend had the 'fat drug' in London for a fraction of its US price despite being 'the same box made in the same plant by the same company'. Eli Lilly is increasing the wholesale price UK retailers will pay for a middle-sized 5mg dose from £92 to £180, and for the maximum dose, 15mg, from £122 to £330. These costs are likely to be passed on to private patients, of which there are almost one million taking Mounjaro, most of whom will now face the choice of paying the increased rates or stopping the drug. But the NHS has said it will continue prescriptions for patients who had been accessing the drugs privately if they meet certain criteria. The health service has a commercial deal in place to roll out the jab at a cheaper price. The cost of a prescription to patients is £9.90. A letter from NHS officials to GPs seen by The Telegraph said the NHS could continue treatment 'for people that have previously accessed tirzepatide through a private provider' if they meet eligibility criteria when assessed by a weight management service. Under current guidance, patients must have a body mass index of 40 or more 'in addition to four or more qualifying comorbidities', such as diabetes and high blood pressure, as part of a phased rollout. From next April, people with a BMI of 35 or more will also be able to get the jab on the NHS, with plans to eventually roll it out to more than three million. People accessing the anti-obesity injections privately are supposed to have a BMI of more than 30, but some people have been 'cheating the system' in order to access it, according to Wes Streeting, the Health Secretary. It is not known how many people will be eligible to move over to an NHS prescription from a private one. There were 32,000 patients waiting for an appointment at a weight management service in the community as of the end of June. While the majority of patients are being seen within 18 weeks, more than 2,000 have been waiting for more than a year. NHS officials also said GPs should tell patients asking for weight-loss jabs if they are not currently eligible. This includes those who may have started treatment with a BMI of more than 40 but is now less. 'We recognise this may be disappointing for people,' the update said, adding that doctors 'could provide reassurance to the person that stopping tirzepatide, that is being taken for its licensed weight loss indication, is not known to cause withdrawal symptoms, but that they should continue, where appropriate, a reduced-calorie diet and increased physical activity if they want to reduce the risk of weight regain'. It said anyone with questions about stopping the drugs should be directed back to their private provider. More people could also turn to the other weight-loss jab available in the UK, rival brand Wegovy, made by Danish firm Novo Nordisk. A spokesman for the company, which also makes Ozempic, said they had 'no plans of changing our offering in the UK'. 'Our focus is on supporting patients, and we are committed to ensuring that our medicines are not only innovative but also accessible and affordable for those who need them most,' they said. 'Our mission is to help create a healthier world by addressing some of the most pressing threats to public health – including obesity, diabetes and cardiovascular disease.' A Department of Health spokesman said: 'This government is committed to ensuring that more people have access to these revolutionary drugs when needed, and crucially that they are able to so do in a safe and controlled way. 'Pricing in the private market is a matter for Eli Lilly and for private providers of weight loss and diabetes services. Eli Lilly are working with providers to maintain patient access. 'NHS commissioning of tirzepatide, based on clinical priority, is unaffected by the change in list price.'

Birmingham nursing home downgraded to inadequate
Birmingham nursing home downgraded to inadequate

BBC News

time36 minutes ago

  • BBC News

Birmingham nursing home downgraded to inadequate

A care home in Birmingham has been rated inadequate by inspectors after failing to meet expected safety standards. Fountain Nursing and Care Home, on Fountain Road, was placed into special measures following an inspection by the Care Quality Commission (CQC).Its rating was downgraded from good after the body found nine breaches of regulations, despite residents and family members "generally positive" about the found that one resident, known to be at risk of falls, had sustained a head injury after falling - but staff did not seek timely medical advice or report it properly. The home has been contacted by the BBC for comment. The care home, run by a company of the same name, provides personal and nursing care - with 26 people living there at the time of the inspection in May. Inspectors said they were "disappointed" that the quality of care had "deteriorated considerably" since the previous inspection in 2020. The breaches related to a raft of areas including person-centred care, dignity and respect, consent, risk management, nutrition and hydration, premises and equipment safety, staffing, and Lyndon, CQC deputy director of operations in Birmingham, said the quality of leadership at the home had declined. She said: "Our experience tells us when a service isn't well-led, they find it difficult to provide good care in the other areas we look at, which is what we found here."Staff and leaders didn't recognise or report safeguarding concerns to protect people from potential abuse or harm."We saw leaders also failed to provide sufficient guidance for staff to safely manage people's health conditions and risks. They didn't ensure staff were adequately trained and had the relevant skills and knowledge to provide safe found the manager of the service was approachable, listened to concerns and supported also said residents and their relatives knew how to give feedback and felt comfortable raising the report noted that leaders "didn't provide clear information and guidance for staff" on supporting people with known health also said staff did not manage residents' nutrition and hydration needs "effectively". Follow BBC Birmingham on BBC Sounds, Facebook, X and Instagram.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store